Table 2. Prevalence of thromboembolic events and mucosal organ involvement in patients with isolated IgA anti-β2GPI versus controls.

Thromboembolic events	Isolated IgA anti-β2GPI	Controls	Odd ratio	95% CI	p value
Entire cohort (n = 56)
≥1 thromboembolic event	27	14	2.793	1.263–6.172	0.018
No thromboembolic event	29	42
SLE (n = 31)
≥1 thromboembolic event	14	5	4.282	1.338–13.569	0.026
No thromboembolic event	17	26
Non-SLE (n = 25)
≥1 thromboembolic event	11	9	1.397	0.456–4.276	0.773
No thromboembolic event	14	16
Mucosal organ involvement
≥1 mucosal organs	49	37	3.595	1.394–9.223	0.013
No mucosal organs	7	19